International Journal of Advanced Research in Biological Sciences ISSN: Coden: IJARQG(USA)

Similar documents
Predictive Value of Dialysate Cell Counts in Peritonitis Complicating Peritoneal Dialysis

OUTCOME FOLLOWING CAPD-ASSOCIATED GRAM-NEGATIVE PERITONITIS

Predictors of Peritonitis in Patients on Peritoneal Dialysis: Results of a Large, Prospective Canadian Database

Fungal peritonitis in peritoneal dialysis: a 10 year retrospective analysis in a single center

PERSISTENT SYMPTOMATIC INTRA-ABDOMINAL COLLECTION AFTER CATHETER REMOVAL FOR PD-RELATED PERITONITIS

Predictor factors of peritoneal dialysis-related peritonitis

International Journal of Infectious Diseases

Improvement in Pittsburgh Symptom Score Index After Initiation of Peritoneal Dialysis

Presternal Catheter Design An Opportunity to Capitalize on Catheter Immobilization

The Sudan Peritoneal Dialysis Program: Three Years of Momentum

Increased peritoneal dialysis utilization and improved patient survival over a 20-year period: data from a Portuguese Peritoneal Dialysis Unit

Role of predictors and rapid diagnosis of fungal peritonitis in CAPD patients

Peritonitis before Peritoneal Dialysis Training: Analysis of Causative Organisms, Clinical Outcomes, Risk Factors, and Long-Term Consequences

Fungal peritonitis in patients undergoing continuous ambulatory peritoneal dialysis in Qatar

Although long-term outcomes of hemodialysis and

Philip K.T. Li MD, FRCP, FACP

Effects of infectious complications on patients survival in peritoneal dialysis

Outcomes of Peritonitis in Children on Peritoneal Dialysis: A 25-Year Experience at Severance Hospital

The Association between Peritoneal Dialysis Modality and Peritonitis

Microbiology Risk Factors and Outcomes of Peritonitis in Tunisian Peritoneal Dialysis Patients

4th self-care dialysis symposium 6th & 7th June 2018

Peritonitis and catheter exit-site infection in patients on peritoneal dialysis at home 1

02/10/2017. Major Infectious Complications. Learning Objectives. Modalities. At the end of this session the listener will be able to:

Reinitiation of peritoneal dialysis after catheter removal for refractory peritonitis

Early Onset Peritoneal Dialysis-Related Peritonitis. Abstract. imedpub Journals Vol.2 No.3:44.

Geographic and Educational Factors and Risk of the First Peritonitis Episode in Brazilian Peritoneal Dialysis Study (BRAZPD) Patients

Assisted Peritoneal Dialysis

18/03/2014 PD: INFECTIOUS COMPLICATIONS. Infectious complications in PD patients. Some facts. Exit site infection. Tunnel infection.

PART ONE. Peritoneal Kinetics and Anatomy

Princess Alexandra Hospital, Brisbane

03/20/2019. Thank you for the invitation to speak. I have no conflicts of interest

Editorial. Renal Replacement Therapy in CKD: an update from the Latin American Registry of Dialysis and Transplantation

Peritoneal Dialysis Adequacy: Not Just Small- Solute Clearance

Peritoneal Fluid Analysis and Result Interpretation: Implications for Nursing Care

Pichaya Tantiyavarong, 1,2 Opas Traitanon, 2 Piyatida Chuengsaman, 3 Jayanton Patumanond, 1 and Adis Tasanarong Introduction

CHAPTER 6 PERITONEAL DIALYSIS. Neil Boudville. Hannah Dent. Stephen McDonald. Kylie Hurst. Philip Clayton Annual Report - 36th Edition

Introduction/objective: Adinamic bone disease (ABD) is a common finding in peritoneal. dialysis (PD) and is associated with a

IMPACT OF THE BAG EXCHANGE PROCEDURE ON RISK OF PERITONITIS. Jie Dong and Yuan Chen

The CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES

Chapter 12 PERITONEAL DIALYSIS

Predictors of Patient Survival in Continuous Ambulatory Peritoneal Dialysis 10-Year Experience in 2 Major Centers in Tehran

A clinical audit to compare peritonitis rates between peritoneal dialysis delivery systems

Original Articles. Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis

Concern about the decreasing use of peritoneal dialysis

Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease

CHAPTER 6 PERITONEAL DIALYSIS

BAPN 2016 Audit of dialysis access and complications in UK children

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

APD and its new frontier. Roberto Pecoits-Filho, MD, PhD, FACP, FASN

THERAPEUTIC INTERVENTIONS TO PRESERVE RESIDUAL KIDNEY FUNCTION. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle

02/27/2018. About half million people in the US with ESRD. HD is currently more prevalent than PD

Original Article Diagnostic and prognostic significance of procalcitonin and endotoxin in peritoneal dialysis-related peritonitis

The Association between Exit Site Infection and Subsequent Peritonitis among Peritoneal Dialysis Patients

CHAPTER 12. Peritoneal Dialysis

Update in Peritoneal dialysis

The dilemma in pursuing dialysis in developing

GUIDELINES FOR PERFORMING AN INTRAPERITONEAL UROKINASE LOCK

The CARI Guidelines Caring for Australians with Renal Impairment. Guidelines

Risk Factors Associated with Nosocomial Peritonitis in Children on Peritoneal Dialysis

Strategies to Prevent Peritoneal Dialysis Failure

SIMULTANEOUS CATHETER REPLACEMENT FOR INFECTIOUS AND MECHANICAL COMPLICATIONS WITHOUT INTERRUPTION OF PERITONEAL DIALYSIS

Renal Unit. Catheter Related Bacteraemia Guidelines

Outcome of Immediate Use of the Permanent Peritoneal Dialysis Catheter in Children with Acute and Chronic Renal Failure

6. Type of peritoneal dialysis catheter

RECURRENT INFECTION AND CATHETER LOSS IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS

CHAPTER 6 PERITONEAL DIALYSIS. Fiona Brown Aarti Gulyani Stephen McDonald Kylie Hurst Annual Report 35th Edition

Association between causes of peritoneal dialysis technique failure and all-cause mortality

From Peritoneal Dialysis to Hemodialysis How could we improve the transition? Th Lobbedez CHU de Caen Self Dialysis Meeting 22 May 2014

Advances in Peritoneal Dialysis, Vol. 23, 2007

Home Education Impact on Peritoneal Dialysis-Associated Peritonitis Episode

PART FIVE. Catheters and Connectors

Outcomes of chronic dialysis in Korean children with respect to survival rates and causes of death

PD In Acute Kidney Injury. February 7 th -9 th, 2013

WHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington

Patients with underlying liver disease and ascites are

Reviews in Infection

Experts in all modalities The Expanding Role of PD Trends and Advances That Have Increased the Viability and Utilization of Peritoneal Dialysis

Protective effect of N-acetylcysteine from drug-induced ototoxicity in uraemic patients with CAPD peritonitis

Management of End Stage Renal Disease-Bangladesh Perspective

The peritoneal equilibration test (PET) was developed THE SHORT PET IN PEDIATRICS. Bradley A. Warady and Janelle Jennings

Encapsulating Peritoneal Sclerosis (EPS)

Peritonitis outcomes in patients with HIV and end-stage renal failure on peritoneal dialysis: a prospective cohort study

Ana Paula Bernardo. CHP Hospital de Santo António ICBAS/ Universidade do Porto

Hepatitis B vaccination in Haemodialysis Patients: The Impact of Local Endemicity

5. Indications for the use of urokinase in peritoneal dialysis associated peritonitis

A Randomized Controlled Trial Comparing Mupirocin and Polysporin Triple Ointments in Peritoneal Dialysis Patients: The MP 3 Study

Early Estimation of High Peritoneal Permeability Can Predict Poor Prognosis for Technique Survival in Patients on Peritoneal Dialysis

Proceedings of the ISPD 2006 The 11th Congress of the ISPD /07 $ MAXIMIZING THE SUCCESS OF PERITONEAL DIALYSIS IN HIGH TRANSPORTERS

National Surveillance System for Dialysis Centre and Dialysis Associated Diseases

Renal replacement therapy for patients with diabetes mellitus in Hong Kong

Chapter 10: Dialysis Providers

Evaluation and management of nutrition in children

Focus on peritoneal dialysis training: working to decrease peritonitis rates

Meeting the Guidelines for End-of-Life Care

The Physiology of Peritoneal Dialysis As Related To Drug Removal

Imaging of Peritoneal Catheter Tunnel Infection Using Positron-Emission Tomography

Dialysis-associated peritonitis in children

Chapter 2 Peritoneal Equilibration Testing and Application

New Zealand. Dialysis and Transplantation Audit

Advances in Peritoneal Dialysis, Vol. 29, 2013

Transcription:

International Journal of Advanced Research in Biological Sciences ISSN: 2348-8069 www.ijarbs.com Coden: IJARQG(USA) Research Article Incidence of peritonitis, causative organism, catheter and patient outcome, single center experience. Ayman Aly Seddik ¹ ², Amna Khalifa Alhadari², Fakhria Al Alawy², Abdelrahman Khedr¹ 1 Department of Medicine, Faculty of Medicine Ain Shams University, Cairo, Egypt 2 Nephrology Department, Dubai Hospital, Dubai Health Authority *Corresponding author: Seddik500@gmail.com Abstract Introduction: Peritonitis in the peritoneal dialysis (PD) patient is defined by the International Society for Peritoneal Dialysis (ISPD) as the presence of two of the following three criteria: (1) signs and symptoms such as fever, abdominal pain/tenderness ; (2) >100 white blood cells/ml dialysate fluid, of which >50% are neutrophils; and (3) identification of the organism in the PD fluid (1). Peritonitis still represents the main acute complication of peritoneal dialysis (PD) and is a leading cause of hospitalization catheter loss, and technique failure (2). Patients and Methods: Quantitative approach, retrospective study. We analyzed a database of patients from the Nephrology Service at Dubai hospital, Dubai health authority from January 1999 till December 2012 The analysis included patients in PD for more than 3 months and with complete information. We collected data regarding the catheter and patient outcome following recorded peritonitis episodes. The rate of peritonitis was expressed as risk of a peritonitis episode per year (ep./year) and calculated in accordance with the ISPD recommendations. Results: 54 patients studies over 13 years 29 female patients (56%) and 23 male patients (44%), higher number of patients in 40-60 and > 60 years groups 46.2% & 36.5% respectively. the calculated peritonitis episode per patient year where total peritonitis episodes were 0.408 episodes per patient year With highest recorded for gram positive organism in patient culture 0.132 followed by culture negative 0.126 episodes per patient year and the lowest incidence found for fungal infection 0.024 episodes per patient year. prevalence of causative organism as per culture results, the highest was for gram positive organisms and culture negative episodes 35.3 % and 30.7% respectively. outcome of catheter post peritonitis episodes we found that the episodes resulted in catheter removal in 54 episodes ( 35.3% ) and catheters were salvaged in 99 episodes (64.7%). patients continued on peritoneal dialysis following peritonitis episodes in 90 (58.8%) while 32 episodes needed temporary Hemodialysis (HD), permenant HD in 24 episodes (15.7%) and mortality was reported in 7 episodes (4.6% ). Discussion: This study provides an overview of the incidence of peritonitis and the microbiological profile of a single PD center in Dubai, UAE The incidence of peritonitis per patient year shown in our study 0.408 episode per patient year this ( almost one episode every 26 patient months ) which comes in acc ordance with The 2005 recommendations from the International Society of Peritoneal Dialysis (ISPD) recommend that the unit should have as a goal a rate not exceeding one episode every 18 months, or 0.67 ep./year (1). Conclusion: we may conclude that the rate of peritonitis episodes per patient year of the patients studied is within the minimum recommended by the guidelines, but short of the latest goals achieved in some centers we observed that there was an improvement over the last few years which we attribute to the improvement in training and retraining of patient and care giver enrolled in the program, staff continuous education, assignment of dedicated peritoneal dialysis nurses, higher rate of using automated peritoneal dialysis machines and the structured follow up of our patients with monthly peritoneal dialysis clinic follow up and This data reinforce the importance of training and constant monitoring for the improvement of services, with a consequent emphasis on patient safety. Keywords: Peritonitis, peritoneal dialysis, fungal peritonitis, gram positive peritonitis, gram negative peritonitis, culture negative peritonitis Introduction SOI: http://s-o-i.org/ 1.15/ijarbs-2-11-21 Peritonitis remains the major complication in patients on peritoneal dialysis (PD), peritonitis rates vary in the literature, reflecting differences between countries, study design and populations (1). 155 Peritonitis in the peritoneal dialysis (PD) patient is defined by the International Society for Peritoneal Dialysis (ISPD) as the presence of two of the following three criteria: (1) signs and symptoms

such as fever, abdominal pain/tenderness; (2) >100 white blood cells/ml dialysate fluid, of which >50% are neutrophils; and (3) identification of the organism in the PD fluid (1). Int. J. Adv. Res. Biol. Sci. 2(11): (2015): 155 164 diagnosis and prompt management of episodes of peritonitis to prevent membrane damage and subsequent failure and the morbidity and mortality associated with peritonitis (8). Peritonitis still represents the main acute complication of peritoneal dialysis (PD) and is a leading cause of hospitalization catheter loss, and technique failure (2). It is also a common cause of death in PD patients and has been described as one of the leading causes of transfer to Hemodialysis (HD) (3). The decline of peritonitis rates during the last decades has mostly been achieved by improvements in factors relating PD technique such as the change to plastic bags, the introduction of the Y-set-twin-bag connection system (4). Despite the significant drop in the peritonitis rates since the 1980 from approximately 6 episodes/patient years, the peritonitis rate published in the literature remains constant at approximately 0.35 episodes/patient years (5). The development of disconnect systems has had an important effect on overall reduction of the incidence of peritonitis episodes, particularly those due to skin organisms. A variety of micro-organisms may cause PD peritonitis. Gram-positive organisms, particularly Staphylococcus aureus and S. epidermidis, have been the most frequent pathogens However, in patients utilizing the disconnect systems, with the reduction in the incidence of gram-positive staphylococcus peritonitis; the relative incidence of gram-negative infection has increased (6). Patients with peritonitis usually present with cloudy fluid and abdominal pain. However, peritonitis should always be included in the differential diagnosis of the PD patient with abdominal pain, even if the effluent is clear. However, in the PD patient with abdominal pain and clear fluid, other causes such as pancreatitis should be investigated (7). Cloudy effluent will almost always represent infectious peritonitis but there are other causes. The differential diagnosis include: Culture-positive infectious peritonitis, Infectious peritonitis with sterile cultures, Eosinophilia of the effluent, Hemoperitoneum, Malignancy, Chylous effluent (8). The international society of peritoneal dialysis constantly emphasize the importance of early Patients and Methods Quantitative approach, retrospective study. We analyzed a database of patients from the Nephrology Service at Dubai hospital, Dubai health authority from January 1999 till December 2012 The analysis included patients in PD for more than 3 months and with complete information. We collected clinical and demographic data such as age, gender, time on PD, reason for being taken off therapy, number of peritonitis episodes,, and causing microorganism. We collected data regarding the catheter and patient outcome following peritonitis episodes. The rate of peritonitis was expressed as risk of a peritonitis episode per year (ep./year) and calculated in accordance with the ISPD recommendations (8). To determine the rate of peritonitis and/or peritonitis culture result, we calculated the number of patients/day (pat.day), peritonitis episodes per patient/year (episodes/pat.year) and peritonitis episodes per year (episodes/year). To calculate the number of pat.day, we summed up the total number of days each patient was followed up. To determine the number of episodes/pat.year and episode/year, we used specific formulas, where episode/pat.year is equal to the total number of pat/day divided by 365 and the result is divided by the number of peritonitis episodes. Protocol was reviewed and approved by ethical and research committee, patient and medical records confidentiality were assured. All data were tabulated, computerized and gone through statistical analysis using SPSS 16 Program. Results Demographic data shown in figure (1) for patients involved demonstrating higher number of females 29patients (56%) and the patient age group distribution showing higher number of patients in 40-60 and > 60 years groups 46.2% & 36.5% respectively. 156

Figure 2 showed the number of peritonitis episodes per year, table (1) demonstrate the distribution of peritonitis episode each year by peritoneal fluid culture result. Table (2) showed the calculated peritonitis episode per patient year where total peritonitis episodes were 0.408 episodes per patient year. With highest recorded for gram positive organism in patient culture 0.132 followed by culture negative 0.126 episodes per patient year and the lowest incidence found for fungal infection 0.024 episodes per patient year. Figure (3) and table (3) showing the prevalence of causative organism as per culture results, the highest was for gram positive organisms and culture negative episodes 35.3 % and 30.7% respectively. As we followed the outcome of catheter post peritonitis episodes we found that the episodes resulted in catheter removal in 54 episodes (35.3%) and catheter were salvaged in 99 patients (64.7%).as shown in figure (4) and table (4). Figure (5) and table (5) demonstrate Follow up patient outcome post peritonitis episodes the majority of patients continued on peritoneal dialysis following peritonitis episodes 90 (58.8%) while 32 patients needed temporary Hemodialysis (HD) after catheter removal till the insertion of new catheter after infection clearance. Int. J. Adv. Res. Biol. Sci. 2(11): (2015): 155 164 Patients were shifted permanently to HD post peritonitis episodes in 24 episodes (15.7%) and mortality was reported in 7 episodes (4.6%). Figure ( 6-7) and table (6-7) showed Further analysis of the data to define the catheter outcome and patient outcome for different causative organisms demonstrated the highest rate of catheter removal reported with fungal culture and gram negative culture (100% ) & (48.8%) respectively. The patient outcome analysis showed highest mortality rate with fungal infection episodes 2 (22%) followed by gram negative culture 3 episodes (7%) and gram positive 2 episodes (3.7%). Most of the patient who experienced gram positive peritonitis continued on peritoneal dialysis 38 (70.4%) where the patient with gram negative culture needed temporary HD in 16 episodes (37.2% ) and shift to permanent HD IN 6 EPISODES (14%). Peritonitis caused by fungal infection ended in cessation of peritoneal dialysis in higher proportion of episodes 6 (66.7%) and temporary HD in 1(11.1%). Patient with culture negative peritonitis showed higher proportion of continuation on PD 34 episodes (72.3%) with no recorded mortality with temporary HD in 6 episodes (12.8%) and permanent HD IN 7 episodes (14.9%). Figure 1 Patient distribution by gender and age group 157

Figure 2 Peritonitis episodes 1999-2012 Table (1) Peritonitis episodes 1999-2012 by causative organism 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Episodes of peritonitis 5 4 2 5 11 13 11.00 23.00 13 15 10 20 9 12 Gram +ve 2 1 0 0 4 3 4.00 7.00 4 6 4 6 3 6 Gram-ve 1 1 1 2 3 2 5.00 6.00 5 5 3 4 4 4 Fungi 0 0 0 0 2 0 1.00 2.00 0 1 0 2 1 0 Culture -ve 1 2 1 3 2 8 1.00 8.00 3 3 3 10 1 2 Table (2) Peritonitis episodes by causative organisms per patient year Episodes Numbers Episode/ Patient year Total peritonitis episodes 153.00 0.403 Gram +ve episodes 50.00 0.132 Gram-ve episodes 46.00 0.121 Fungi episodes 9.00 0.024 Culture -ve episodes 48.00 0.126 158

Figure 3 Peritonitis episodes culture results Table (3) Peritonitis episodes culture results Count Percent Organism Culture negative 47 30.7% Fungi 9 5.9% Gram positive 54 35.3% Gram negative 43 28.1% Figure 4 Peritoneal cathter outcome post peritonitis episodes Table (4) Peritoneal cathter outcome Frequency Percent Cathter removed 54 35.3% Cathter salvaged 99 64.7% Total 153 100.0 159

Figure 5 patient outcome post peritonitis episodes Table (5) Patient outcome post peritonitis episode Frequency Percent Continue PD 90 58.8% Deceased 7 4.6% Permanent HD 24 15.7% Temporary HD 32 20.9% Total 153 100.0% Figure 6 Cathter outcome accounting to culture results 160

Table (6) cathter outcome according to culture result cathter salvaged cathter removed % cathter salvaged % cathter removed Gram positive 54.0 39.0 72.2% 27.8% Gram negative 43.0 22.0 51.2% 48.8% Fungi 9.0 0.0 0.0% 100.0% Culture negative 47.0 38.0 80.9% 19.1% Figure 7 Patient outcome accounting to culture result Table (7) Patient outcome according to culture results Conyinue PD Deceased Temporary HD Permanent HD Gram positive 38 2 9 5 Gram negative 18 3 16 6 Fungi 0 2 1 6 Culture negative 34 0 6 7 Conyinue PD Deceased Temporary HD Permanent HD Gram positive 70.4% 3.7% 16.7% 9.3% Gram negative 41.9% 7.0% 37.2% 14.0% Fungi 0.0% 22.2% 11.1% 66.7% Culture negative 72.3% 0.0% 12.8% 14.9% 161

Discussion This study provides an overview of the incidence of peritonitis and the microbiological profile of a single PD center in Dubai, UAE Our sample group similar to studies in Latin America (Brazil and Argentina) with regards to higher proportion of elderly patients > 60 years. However our patients showed a higher proportion of female (56%) while the literature showed male predominance (9-10). The incidence of peritonitis per patient year shown in our study 0.403 episode per patient year this (almost one episode every 26 patient months) which comes in accordance with The 2005 recommendations from the International Society of Peritoneal Dialysis (ISPD) recommend that the unit should have as a goal a rate not exceeding one episode every 18 months, or 0.67 ep./year (8). However, in 2011, the ISPD published a document for risk reduction of peritoneal infections associated with dialysis, which suggests that the rate of 0.36 ep./year, or one episode every 33 months, can be achieved by most programs a rate much lower than achieved currently by our center (11). Other centers in Taiwan showed even a lower rate of peritonitis per year 0.06 episodes per patient year, while some centers in Scotland showed higher 0.60 episodes per patient year, these variations in rate of peritonitis among different centers is multifactorial but they are most likely associated with differences in training, patient selection and protocols to prevent infection. (12). Moraes et al., in a retrospective analysis of a single center in Brazil, reported a rate of 0.74 ep./year in the period between 2000 and 2005, but when they considered the 25-year experience, the rates were 0,84 episode per patient year, rate higher than reported in our study (13). Multicenter brazilian study showed peritonitis rate of 0.4 episodes per patient year almost similar to results obtained from our study (14). According to Barreti et al. the main causative agent of peritonitis in the world is the gram positive coagulase negative staphylococci ; however Staphylococcus aureus is associated with more severe episodes and increased risk of hospitalization, catheter removal and death This come in accordance of our results with Int. J. Adv. Res. Biol. Sci. 2(11): (2015): 155 164 162 gram positive culture the main cause of peritonitis episodes 54 ( 35.3%).(15) Episodes of gram positive peritonitis are generally related to contamination at the time of connection or line contamination. Since these are germs from the skin natural microflora, Staphylococcus aureus and coagulase negative staphylococci are present mainly in the hands, which is the primary means of intraluminal contamination, demonstrating the relevance of effective training in which continuing education is important; thus preventing patients from forgetting the skills acquired during training - resulting in later damage (16). Our culture negative episodes of 30.7 % results is higher than recommendation by international society of peritoneal dialysis of culture negative episodes not exceeding 20% of cultures which can be attributed to collection techniques or lower threshold of considering patients diagnosis of peritonitis hence collecting culture on suspicious of peritonitis with abdominal pain with or without cloudy effluent (11). Our subsequent data analysis of the studied population showed the higher proportion of patient continued peritoneal dialysis post peritonitis episodes 58.8% with 20.9 % patient needed temporary hemodialysis post peritoneal catheter removal till clearance of infection and introduction of new catheter, 15.7% of patients were shifted permanently to haemodialysis. Mortality rate was 4.6% among the peritonitis episodes a rate slightly higher than reported mortality of 4% in current literature (13). Our fungal peritonitis series constituted 5.9% of all peritonitis episodes in our PD unit. It was similar to the reported other prevalence changing from 2% to10.2%. Subsequent analysis found catheter was removed in 100% of peritonitis episodes immediately after culture growth of fungal species, the highest mortality rate among other groups 22.2% with 66.7% patients shifted permanently to Hemodialysis. this come in accordance with the ISPD guidelines for management of Fungal peritoneal dialysis which recommend catheter removal on fungal growth in culture as there is high recurrence rate and higher mortality among those cohort of patients (11). The main limitation of our study is its retrospective aspect. However, our data indicate the need to implement measures aimed at reducing peritonitis rate per patient year and t he rate for culture negative

peritonitis to the rates recommended by ISPD guidelines, by improving the selection, implementing training and retraining implementing catheter care techniques and education for care giver for improving outcome. Conclusion We may conclude that the rate of peritonitis episodes per patient year of the patients studied is within the minimum recommended by the guidelines, but short of the latest goals achieved in some centers, as well as the characterization of by microorganisms episodes per patient and median value of the program. with respect to the median of peritonitis episodes of the program, we observed that there was an improvement over the last few years which we attribute to the improvement in training and retraining of patient and care giver enrolled in the program, staff continuous education, assignment of dedicated peritoneal dialysis nurses, higher rate of using automated peritoneal dialysis machines and the structured follow up of our patients with monthly peritoneal dialysis clinic follow up and This data reinforce the importance of training and constant monitoring for the improvement of services, with a consequent emphasis on patient safety. References Int. J. Adv. Res. Biol. Sci. 2(11): (2015): 155 164 1. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al.; ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005;25: 107-31. 2. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA(CANUSA) peritoneal dialysis study group, Journal of the American Society of Nephrology, vol. 7, no. 2, pp. 198 201996 3. S. H. Chung, O. Heimb urger, B. Lindholm, and H. B. Lee, Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre, Nephrology Dialysis Transplantation, vol. 20, pp. 1207 1213, 2005. 4. G. F. M. Strippoli, A. Tong, D. Johnson, F. P. Schena, and J. C. Craig, Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials, Journal of the American Society of Nephrology, vol. 15, no. 10, pp. 2735 2746, 2004. 5. Whaley-Connell, B. S. Pavey, R. Satalowich et al., Rates of continuous ambulatory peritoneal dialysisassociated peritonitis at the University of Missouri, Advances in Peritoneal Dialysis, Conference on Peritoneal Dialysis, vol. 21, pp. 72 75, 2005. 6. William F. Keane,1 George R. Bailie,2 Elizabeth Boeschoten,3 Ram Gokal,4 Thomas A. Golper,5 Clifford J. Holmes,6 Yoshindo Kawaguchi,7 Beth Piraino,8 Miguel Riella,9 Stephen Vas 10, ISPD Guidelines/Recommendations, Peritoneal Dialysis International, Vol. 20, pp. 396 411,2000. 7. Fussholler A, Zur Nieden S, Grabensee B, Plum J. Peritoneal fluid and solute transport: influence of treatment time, peritoneal dialysis modality, and peritonitis incidence. J Am Soc Nephrol 2002; 13(4):1055 60. 8. Beth Piraino,1 George R. Bailie, Judith Bernardini, Elisabeth Boeschoten, Amit Gupta, Clifford Holmes, Ed J. Kuijper, Philip Kam-Tao Li, Wai-Choong Lye, Salim Mujais, David L. Paterson, Miguel Perez Fontan, Alfonso Ramos, Franz Schaefer, and Linda Uttley, Peritoneal Dialysis-Related Infections Recommendations: 2005 Update Peritoneal Dialysis International, Vol. 25, pp. 107 131 9. Sesso RC, Lopes AA, Thomé FS, Lugon JR, Santos DR. Relatório do censo brasileiro de diálise de 2010. J Bras Nefrol 2011;33:442-7 10.Sesso Rde C, Lopes AA, Thomé FS, Lugon JR, Burdmann Ede A. Brazilian dialysis census, 2009. J Bras Nefrol 2010; 32:374-8. 11.Piraino B, Bernardini J, Brown E, Figueiredo A, Johnson DW, Lye WC, et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int 2011; 31:614-30. 12.Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, et al.; International Society for Peritoneal Dialysis. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 2010;30:393-423. DOI: http://dx.doi.org/10.3747/pdi.2010.00049 13.Moraes TP, Pecoits-Filho R, Ribeiro SC, Rigo M, Silva MM, Teixeira PS, et al. Peritoneal dialysis in Brazil: twenty-five years of experience in a single center. Perit Dial Int 2009;29:492-8. 14.Lobo JVD, Villar KR, Andrade Júnior MP, Bastos KA. Preditores de peritonite em pacientes em um programa de diálise peritoneal. J Bras Nefrol 2010; 32:156-64. 15.Barretti P, Bastos KA, Dominguez J, Caramori JC. Peritonitis in Latin America. Perit Dial Int 2007;27:332-9. 16.Judith Bernardini, Valerie Price, and ana Figueiredo, ispd guidelines/recommendations, peritoneal dialysis patient training, Peritoneal Dialysis International, Vol. 26, pp. 625 632, 2006. 163

17.Goldie SJ, Kiernan-Tridle L, Torres C, Gorban- Brennan N, Dunne D, Kliger AS, Finkelstein FO. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 1996; 28; 86-91. 18.Wang AY, Yu AW, Li PK, Lam PK, Leung CB, LAI KN, Lui SF. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis 2000; 36: 1183-1192. 19.Unal A, Kocyigit I, Sipahioglu MH, Tokgoz B, Oymak O, Utas C. Fungal peritonitis in peritoneal dialysis: an analysis of 21 cases. Int Urol Nephrol2011; 43: 211-213. 164